文献速递功能神经外科

激光间质热疗与开放切除术治疗药物难治性癫痫的荟萃分析

A comparative assessment of laser interstitial thermal therapy and open resective surgery for drug-resistant epilepsy: a meta-analysis of 3873 patients.
PubMed 文献 · J Neurosurg · 2025-09-05

该荟萃分析纳入15项队列研究共3873例药物难治性癫痫患者,比较激光间质热疗(LITT)与开放切除术(ORS)。总体分析显示ORS无发作率更高,但倾向性评分匹配研究和颞叶癫痫亚组中两组无发作率相似;LITT住院时间更短、并发症率更低。

要点

  • 总体未匹配分析中ORS无发作率高于LITT(67.1% vs 52.5%,RR 0.78)。
  • 倾向性评分匹配研究及颞叶癫痫亚组中两组无发作率无显著差异。
  • LITT住院时间更短、并发症率及永久性神经功能缺损率更低。

核心结论

  • 在未匹配研究中ORS的无发作率高于LITT,但匹配队列分析显示两种干预的无发作率无差异。
  • LITT具有更短的住院时间和更低的并发症率。

研究设计与样本

  • 荟萃分析,检索截至2024年3月14日的文献,纳入15项比较LITT与ORS治疗药物难治性癫痫的队列研究,共3873例患者。

主要发现

  • LITT组无发作率为52.5%(95%CI 0.453-0.597,I2=47.4%),ORS组为67.1%(95%CI 0.602-0.739,I2=57.4%)。
  • LITT相比ORS的无发作率风险比RR为0.78(95%CI 0.70-0.88,p≤0.0001)。
  • 倾向性评分匹配研究中两组无发作率RR为0.85(95%CI 0.63-1.15,p=0.30),颞叶癫痫亚组RR为0.88(95%CI 0.67-1.14,p=0.34)。
  • LITT组住院时间平均缩短2.95天(95%CI 1.12-4.78,p<0.00001)。
  • LITT组并发症率RR为0.54(95%CI 0.37-0.79,p<0.002,I2=32%),缺血性卒中RR为0.15(95%CI 0.04-0.65,p=0.01),永久性神经功能缺损RR为0.13(95%CI 0.05-0.36,p<0.0001)。

临床怎么用

  • 对于药物难治性癫痫患者,LITT可作为开放切除术的微创替代选择,尤其适用于关注住院时间和并发症风险的患者。
  • 在颞叶癫痫患者中,LITT与ORS的无发作率相似,可个体化选择术式。

局限性

  • 纳入研究均为队列研究,存在混杂因素,需未来前瞻性匹配研究验证。
  • 未评估术后神经认知随访和生活质量测量等关键结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Open resective surgery (ORS) has become the standard of care for focal drug-resistant epilepsy (DRE). However, minimally invasive surgical alternatives, such as laser interstitial thermal therapy (LITT), have also been shown to be safe and effective. A meta-analysis comparing both treatments is warranted to assess the benefits of each modality for focal DRE. METHODS: A literature search was conducted until March 14, 2024, to identify studies comparing LITT and ORS in patients with DRE. The primary outcomes included seizure freedom (SF), length of hospital stay (LHS), and complication rate (CR). Subgroup analyses were performed based on age, epilepsy etiology, and propensity score-matched (PSM) studies. RESULTS: Of 558 articles, 15 cohort studies met the authors' inclusion criteria, encompassing 3873 patients for analysis. The rate of SF in the LITT group was 52.5% (95% CI 0.453-0.597, I2 = 47.4%) and 67.1% (95% CI 0.602-0.739, I2 = 57.4%) for the ORS group. LITT showed a significantly lower rate of SF compared to ORS (risk ratio [RR] 0.78, 95% CI 0.70-0.88, p ≤ 0.0001). However, when PSM studies (RR 0.85, 95% CI 0.63-1.15, p = 0.30) and studies on patients with temporal lobe epilepsy (TLE) (RR 0.88, 95% CI 0.67-1.14, p = 0.34) were analyzed, the SF rates were similar. Patients who underwent LITT had a significantly shorter LHS (mean difference 2.95 days, 95% CI 1.12-4.78, p < 0.00001), lower CR (RR 0.54, 95% CI 0.37-0.79, p < 0.002, I2 = 32%), lower rate of ischemic stroke (RR 0.15, 95% CI 0.04-0.65, p = 0.01), and lower rate of permanent neurological deficits (RR 0.13, 95% CI 0.05-0.36, p < 0.0001). CONCLUSIONS: Across unmatched studies evaluating focal DRE, ORS showed a higher rate of SF. However, pooled matched-cohort analyses showed no difference between interventions in achieving SF, a trend also noted in the authors' PSM TLE sample. LITT, however, offered significantly shorter LHS and lower CRs. Future prospective studies should match patient populations to control for confounding factors and assess key outcomes, such as postoperative neurocognitive follow-up and quality of life measurements, in order to fully evaluate the risks and benefits of each approach.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Pichardo-Rojas D, Espinosa-Cantú CB, Valenzuela-Rangel AF, et al. A comparative assessment of laser interstitial thermal therapy and open resective surgery for drug-resistant epilepsy: a meta-analysis of 3873 patients. J Neurosurg. 2025. PMID: 40911916. doi:10.3171/2025.4.JNS25386

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。